Showing results (1-10 of 266) with videos related to
Sort By:
Pageof 27
The American Journal of the Medical Sciences|January 1, 1993
New approaches to the therapy of autoimmune diseases: rheumatoid arthritis as a paradigmL W Moreland, L W Heck, W Sullivan, et al.The Journal of Rheumatology|November 1, 1996
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritisL W Moreland, G Margolies, L W Heck, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 1, 1997
Vaccination against rheumatoid arthritis: concepts and progressL W Moreland, W J KoopmanCurrent Opinion in Rheumatology|August 1, 1992
Infection as a cause of reactive arthritis, ankylosing spondylitis, and rheumatic feverL W Moreland, W J KoopmanCurrent Opinion in Rheumatology|August 1, 1991
Infection as a cause of arthritisL W Moreland, W J KoopmanThe Journal of Rheumatology|March 7, 1998
Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritisL W Moreland, T P Haverty, M C Wacholtz, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Synovial Biopsy of the Knee Joint under Direct Visualization by Needle ArthroscopyL W Moreland, J Calvo-Alén, W J KoopmanClinical and Experimental Rheumatology|March 1, 1993
Experience with a chimeric monoclonal anti-CD4 antibody in the treatment of refractory rheumatoid arthritisL W Moreland, P W Pratt, M E Sanders, et al.Annals of the New York Academy of Sciences|November 30, 1993
Effects of nonsteroidal antiinflammatory drugs on bone loss in chronic inflammatory diseaseM K Jeffcoat, M S Reddy, L W Moreland, et al.The Journal of Rheumatology|November 1, 1996
Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritisR E Schrohenloher, W J Koopman, T G Woodworth, et al.Pageof 27